| |
Male (n = 704)
|
Female (n = 769)
|
|---|
|
The use of genetic information is helpful for disease treatment
| |
The use of genetic information is helpful for disease treatment
| |
|---|
|
Agree (n = 554)
|
NEW: Neutral or Disagree (n=115)
|
ORa
|
95%CI
|
P-value
|
Agree (n = 591)
|
NEW: Neutral or Disagree (n=121)
|
ORa
|
95%CI
|
P-value
|
|---|
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|---|
|
High awareness of the Nagahama study
|
191 (34.8)
|
14 (12.4)
|
3.82
|
1.93–7.57
|
<0.001
|
326 (55.6)
|
40 (33.3)
|
2.63
|
1.63–4.24
|
<0.001
|
|
Self-rated understanding of terminology
|
|
High
|
231 (41.8)
|
19 (16.5)
|
1
| | |
168 (28.8)
|
15 (12.6)
|
1
| | |
|
Middle
|
206 (37.3)
|
30 (26.1)
|
0.66
|
0.34–1.29
|
0.223
|
224 (38.4)
|
37 (31.1)
|
0.72
|
0.36–1.42
|
0.342
|
|
Low
|
116 (21.0)
|
66 (57.4)
|
0.24
|
0.12–0.46
|
<0.001
|
192 (32.9)
|
67 (56.3)
|
0.49
|
0.27–0.98
|
0.045
|
|
Concerns
|
|
Financial infusion
|
456 (84.0)
|
60 (52.2)
|
4.37
|
2.49–7.69
|
<0.001
|
473 (81.4)
|
65 (53.7)
|
2.98
|
1.79–4.97
|
<0.001
|
|
Privacy concerns
|
343 (62.5)
|
56 (49.6)
|
0.72
|
0.39–1.32
|
0.284
|
335 (56.9)
|
53 (43.8)
|
1.00
|
0.57–1.74
|
0.993
|
|
Discriminations
|
250 (45.3)
|
39 (34.2)
|
1.38
|
0.47–2.58
|
0.315
|
234 (39.9)
|
38 (31.4)
|
0.77
|
0.43–1.38
|
0.386
|
|
Unexpected negative effects
|
228 (41.4)
|
38 (33.0)
|
1.02
|
0.54–1.93
|
0.963
|
192 (32.6)
|
33 (27.5)
|
0.49
|
0.26–0.90
|
0.022
|
|
Cloned human beings
|
203 (37.0)
|
35 (30.4)
|
0.87
|
0.46–1.66
|
0.682
|
191 (32.5)
|
24 (20.2)
|
2.27
|
1.16–4.46
|
0.017
|
|
Belief
|
|
Company or government bodies use genome information
|
267 (48.8)
|
33 (29.7)
|
1.35
|
0.77–2.36
|
0.299
|
251 (42.7)
|
30 (25.0)
|
1.71
|
0.98–3.00
|
0.060
|
-
aAdjusted according to age and formal education duration
